Brandi Roberts
Chief Financial Officer · Definium Therapeutics, Inc.
- 2024
- Sep 30, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brandi Roberts files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert Barrow - $3.98M in DFTX purchases and sales in the last 12 months
- Mark Sullivan - $1.45M in DFTX purchases and sales in the last 12 months
- Daniel Karlin - $1.07M in DFTX purchases and sales in the last 12 months
- Matthew T. Wiley - $242K in DFTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brandi Roberts?
Brandi Roberts is a corporate insider, tracked as Chief Financial Officer of Definium Therapeutics, Inc. (DFTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brandi Roberts submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Brandi Roberts been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($259K) across all tracked filings.
